{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:26:14Z","timestamp":1793633174213,"version":"4.5.1"},"reference-count":29,"publisher":"Society of Nuclear Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,7,21]]},"published-print":{"date-parts":[[2026,11]]},"DOI":"10.2967\/jnumed.126.272770","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:10:13Z","timestamp":1789063813000},"page":"1755-1763","source":"Crossref","is-referenced-by-count":0,"title":["Cell Surface Expression and PET Imaging Establish DLL3 as a Clinically Actionable Target in Neuroblastoma"],"prefix":"10.2967","volume":"67","author":[{"given":"Salvatore M.","family":"Aspromonte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar Y.","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somali","family":"Gavane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Cihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoqi","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomon A.","family":"Tendler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Alvarez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Brosius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armaan","family":"Siddiquee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Domenico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glorymar","family":"Iba\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Stockfisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Bean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Cochrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Bhanot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish K.","family":"Tickoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Jungbluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Frosina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neerav","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge K.","family":"Lyashchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Schoder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Rudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Daniyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Dunphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia L.","family":"Glade Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakeel","family":"Modak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filemon S.","family":"Dela Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"2026110206250911000_67.11.1755.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09470-w"},{"key":"2026110206250911000_67.11.1755.2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0745-2"},{"key":"2026110206250911000_67.11.1755.3","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01464-y"},{"key":"2026110206250911000_67.11.1755.4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1158\/2767-9764.CRC-22-0137","article-title":"Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastoma","volume":"2","author":"Krytska","year":"2022","journal-title":"Cancer Res Commun."},{"key":"2026110206250911000_67.11.1755.5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJMoa2502099","article-title":"Tarlatamab in small-cell lung cancer after platinum-based chemotherapy","volume":"393","author":"Mountzios","year":"2025","journal-title":"N Engl J Med."},{"key":"2026110206250911000_67.11.1755.6","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2307980"},{"key":"2026110206250911000_67.11.1755.7","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1470-2045(24)00249-3","article-title":"Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1\/2, first-in-human trial","volume":"25","author":"Tendler","year":"2024","journal-title":"Lancet Oncol."},{"key":"2026110206250911000_67.11.1755.8","doi-asserted-by":"crossref","first-page":"e2500724","DOI":"10.1200\/PO-25-00724","article-title":"Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasms","volume":"9","author":"Thummalapalli","year":"2025","journal-title":"JCO Precis Oncol."},{"key":"2026110206250911000_67.11.1755.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00643-z"},{"key":"2026110206250911000_67.11.1755.10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-3909"},{"key":"2026110206250911000_67.11.1755.11","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq529"},{"key":"2026110206250911000_67.11.1755.12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2312"},{"key":"2026110206250911000_67.11.1755.13","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0299"},{"key":"2026110206250911000_67.11.1755.14","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200702009"},{"key":"2026110206250911000_67.11.1755.15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41698-024-00739-y","article-title":"Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms","volume":"8","author":"Serrano","year":"2024","journal-title":"NPJ Precis Oncol."},{"key":"2026110206250911000_67.11.1755.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2014.12.006"},{"key":"2026110206250911000_67.11.1755.17","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-020-03879-7"},{"key":"2026110206250911000_67.11.1755.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30233-7"},{"key":"2026110206250911000_67.11.1755.19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1158\/1535-7163.MCT-25-0437","article-title":"Antitumor activity of trastuzumab deruxtecan in pediatric solid tumors with variable HER2 expression","volume":"25","author":"Burke","year":"2026","journal-title":"Mol Cancer Ther."},{"key":"2026110206250911000_67.11.1755.20","doi-asserted-by":"crossref","first-page":"170033","DOI":"10.1038\/sdata.2017.33","article-title":"Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines","volume":"4","author":"Harenza","year":"2017","journal-title":"Sci Data."},{"key":"2026110206250911000_67.11.1755.21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41392-025-02269-w","article-title":"CAR-T cell therapy for cancer: current challenges and future directions","volume":"10","author":"Zugasti","year":"2025","journal-title":"Signal Transduct Target Ther."},{"key":"2026110206250911000_67.11.1755.22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123776"},{"key":"2026110206250911000_67.11.1755.23","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1111\/cas.14157","article-title":"Delta-like 3 localizes to neuroendocrine cells and plays a pivotal role in gastrointestinal neuroendocrine malignancy","volume":"110","author":"Matsuo","year":"2019","journal-title":"Cancer Sci."},{"key":"2026110206250911000_67.11.1755.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2006.02513.x"},{"key":"2026110206250911000_67.11.1755.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2014.03.008"},{"key":"2026110206250911000_67.11.1755.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2026110206250911000_67.11.1755.27","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2845"},{"key":"2026110206250911000_67.11.1755.28","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1200\/JCO.22.02823","article-title":"Tarlatamab, a first-in-class DLL3-targeted bispecific T-cell engager, in recurrent small-cell lung cancer: an open-label, phase I study","volume":"41","author":"Paz-Ares","year":"2023","journal-title":"J Clin Oncol."},{"key":"2026110206250911000_67.11.1755.29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1158\/0008-5472.CAN-22-1433","article-title":"Immunotherapeutic targeting and PET imaging of DLL3 in small-cell neuroendocrine prostate cancer","volume":"83","author":"Chou","year":"2023","journal-title":"Cancer Res."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.272770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:26:02Z","timestamp":1793629562000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.272770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11,2]]},"published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.2967\/jnumed.126.272770"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.272770","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}